Skip to main content

Table 3 Race and gender stratified trends of incident HPV-related anogenital warts, LSIL, HSIL, and cancer (men only), Cervical LSIL and HSIL, and cancer between 2006 and 2018

From: Comorbidities associated with HPV infection among people living with HIV-1 in the southeastern US: a retrospective clinical cohort study

 

Cases

Joins

Joinpoint Year

AAPC (95% CI)

P-Value

HPV-related CC

 Anogenital warts

 

  

  Men

420

0

19.5 (13.9–25.3)

< 0.0001

  Women

51

0

19.5 (13.9–25.3)

< 0.0001

  Black

312

0

20.4 (15.5–25.5)

< 0.0001

  White

160

0

20.4 (15.5–25.5)

< 0.0001

 Anal HSIL (men only)

71

0

  

  Black

38

0

25.6 (9.7–43.9)

0.0040

  White

33

0

23.1 (−0.2–52.0)

0.052

 Anal cancer (men only)

43

0

5.6 (−4.9, 17.2)

0.29

  Black

18

0

  White

24

0

 Cervical HSIL

 

2

2013,2016

22.5 (−4.5–57.1)

0.11

  Black

54

2

2013,2016

  

  White

25

2

2013,2016

  
 

2006–2013*

29.8 (11.6–50.9)

0.002

 

2013–2016*

−38.3 (− 73.9–45.7)

0.25

 

2016–2018*

179.6 (20.9–546.7)

0.020

 Cervical cancer

12

2

2012, 2016

15.9 (−9.7–48.7)

0.2

  Black

6

2

2012, 2016

  White

6

2

2012, 2016

 

2006–2012*

17.1 (−2.4–40.6)

0.084

 

2012–2016*

−26.4 (− 58.7–31.3

0.27

 

2016–2018*

177.5 (1.3–660.0)

< 0.0001